Literature DB >> 30168027

Pituitary apoplexy after regadenoson myocardial perfusion scan.

Suchith Shetty1, Joseph Gnanaraj2, Sitalakshmi Jayamani Roshan3, Ramzi El Accaoui4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30168027     DOI： 10.1007/s12350-018-1428-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  11 in total

1.  Pituitary apoplexy after myocardial perfusion scintigraphy.

Authors:  L Ferreira-González; M Trigás-Ferrín; Eduardo P Rubin; Pascual Sesma
Journal:  Endocrinol Nutr       Date:  2012-03-15

2.  Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.

Authors:  Hsiao D Lieu; John C Shryock; Gregory O von Mering; Toufigh Gordi; Brent Blackburn; Ann W Olmsted; Luiz Belardinelli; Richard A Kerensky
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Exercise standards for testing and training: a scientific statement from the American Heart Association.

Authors:  Gerald F Fletcher; Philip A Ades; Paul Kligfield; Ross Arena; Gary J Balady; Vera A Bittner; Lola A Coke; Jerome L Fleg; Daniel E Forman; Thomas C Gerber; Martha Gulati; Kushal Madan; Jonathan Rhodes; Paul D Thompson; Mark A Williams
Journal:  Circulation       Date:  2013-07-22       Impact factor: 29.690

4.  Impact of subclinical haemorrhage on the pituitary gland in patients with pituitary adenomas.

Authors:  Yasuyuki Kinoshita; Atsushi Tominaga; Satoshi Usui; Kazunori Arita; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  Clin Endocrinol (Oxf)       Date:  2013-11-09       Impact factor: 3.478

5.  Regadenoson and seizures: a real clinical concern.

Authors:  Vikram Agarwal; E Gordon DePuey
Journal:  J Nucl Cardiol       Date:  2014-08-23       Impact factor: 5.952

6.  2013 American Society of Nuclear Cardiology / MedAxiom Nuclear Survey.

Authors: 
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

7.  The fine structure of blood vessels in chromophobe adenoma.

Authors:  A Hirano; U Tomiyasu; H M Zimmerman
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

8.  Hemorrhage, necrosis, and apoplexy in pituitary adenomas.

Authors:  G Mohr; J Hardy
Journal:  Surg Neurol       Date:  1982-09

9.  Pituitary apoplexy: its incidence and clinical significance.

Authors:  S Wakai; T Fukushima; A Teramoto; K Sano
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

Review 10.  Pituitary Apoplexy.

Authors:  Claire Briet; Sylvie Salenave; Jean-François Bonneville; Edward R Laws; Philippe Chanson
Journal:  Endocr Rev       Date:  2015-09-28       Impact factor: 19.871
View more
  1 in total

1.  Heparin-Induced Pituitary Apoplexy Presenting as Isolated Unilateral Oculomotor Nerve Palsy: A Case Report and Literature Review.

Authors:  Bakr Swaid; Frank Kalaba; Ghassan Bachuwa; Stephen E Sullivan
Journal:  Case Rep Endocrinol       Date:  2019-10-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.